tiprankstipranks
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market
Holding ABVC?
Track your performance easily

ABVC BioPharma, Inc. (ABVC) Financial Statements

88 Followers

ABVC BioPharma, Inc. Financial Overview

ABVC BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.9; its P/E ratio is -0.58; ABVC BioPharma, Inc. is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 389.28K$ 117.14K$ 15.88K$ 6.11K$ 128.27K
Gross Profit$ 388.98K$ 116.95K$ -13.73K$ -66.87K$ 68.04K
EBIT$ 75.11K$ -1.12M$ -2.15M$ -2.12M$ -1.77M
EBITDA$ 82.12K$ -1.11M$ -2.14M$ -2.11M$ -1.76M
Net Income Common Stockholders$ -186.56K$ -1.01M$ -3.32M$ -2.26M$ -1.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 208.15K$ 199.98K$ 568.59K$ 176.08K$ 1.21M
Total Assets$ 14.46M$ 14.63M$ 16.59M$ 9.32M$ 10.73M
Total Debt$ 1.37M$ 2.41M$ 3.41M$ 5.18M$ 5.21M
Net Debt$ 1.17M$ 2.21M$ 2.84M$ 5.01M$ 3.99M
Total Liabilities$ 6.48M$ 6.81M$ 7.53M$ 9.69M$ 9.00M
Stockholders Equity$ 8.36M$ 8.29M$ 9.10M$ -379.31K$ 1.67M
Cash Flow-
Free Cash Flow$ 171.72K$ -1.01M$ -1.38M$ -899.83K$ -1.50M
Operating Cash Flow$ 171.72K$ -1.01M$ -1.36M$ -899.83K$ -1.50M
Investing Cash Flow--$ -73.78K$ -440.57K-
Financing Cash Flow$ -145.39K$ 868.54K$ 1.66M$ -31.59K$ 2.21M
Currency in USD

ABVC BioPharma, Inc. Earnings and Revenue History

ABVC BioPharma, Inc. Debt to Assets

ABVC BioPharma, Inc. Cash Flow

ABVC BioPharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis